PharmNXT Biotech launches first integrated manufacturing unit for single use bioprocessing systems

In line with ‘Make in India’, the government’s flagship programme, Mumbai-based PharmNXT Biotech has launched its first integrated manufacturing unit in Chakan, Pune to provide single use bioprocessing solutions. The state-of-the-art facility has...

Panacea wins contract worth $127 million from WHO, PAHO to supply pentavalent vaccine

Vaccine maker Panacea Biotec said it has received long-term supply contract worth $127.30 million (around INR 1,040 Crore) from UNICEF and Pan American Health Organization (PAHO) for supply of its WHO pre-qualified fully liquid Pentavalent vaccine,..

Logistics4Pharma to expand operations with new ultra deep-freeze capabilities

Logistics4Pharma GmbH, a pharmaceutical cold-chain packaging, storage, warehousing, and logistics specialist, announced that the company is strengthening its service portfolio to satisfy more complex customer needs. The recent investment in...

NICO Corporation announces completion of patient enrollment in first adaptive haemorrhagic stroke trial

NICO Corporation announced that enrollment is now complete for the ENRICH (Early MiNimally-invasive Removal of ICH) randomized controlled trial. The trial compares medical and economic outcomes between early surgical intervention of intracerebral...

Unethical Marketing Practices Rottening Indian Pharma Ecosystem

In India, the care and treatment of COVID-19 at the height of the coronavirus epidemic came to be associated with Dolo-650 mg pills. Profits for the drug's maker, Micro Labs, increased dramatically.

Lupin partners with global agencies to support tuberculosis prevention treatment initiative

Drug firm Lupin said it has tied up with Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI), and other global procurement agencies to support the tuberculosis prevention treatment initiative to be rolled out to 138 countries..

Specialty Pharmaceuticals: Ensuring better Patient Care

The global pharma market is expected to reach USD 1.5 trillion by next year. The industry is also expected to have a compound annual growth rate between 3 and 6 percent in the next five years. The global specialty pharmaceuticals market size is al...

Relief Therapeutics announces exclusive distributor for PKU Golike in US

Relief Therapeutics Holding SA, a Swiss, commercial-stage biopharmaceutical company, announced that it has hired a leading national health services company to serve as exclusive distributor of PKU Golike in the US....

Glenmark to launch Lobeglitazone in India for T2 diabetes in adults

Glenmark Pharmaceuticals Limited has become the first to launch Thiazolidinedione Lobeglitazone in India for the treatment of type 2 diabetes in adults. Marketed under the brand name LOBG, it contains lobeglitazone (0.5 mg) and is to be taken once...

Pfizer COVID vaccine clears Japan panel for use with young children

A Japanese health ministry panel recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old....

© 2025 India Pharma Outlook. All Rights Reserved.